India approves Itolizumab to treat virus patients
The ‘first-in-class’ drug, produced by Indian firm Biocon Ltd, will save lives and help reduce the mortality rate in India, DCGI Chief Mazumdar-Shaw says
The Chinese vaccine developer is in talks with Russia, Brazil, Chile and Saudi Arabia but only a few countries have agreed so far
Some therapists find that remote therapy is so convenient to their patients that they will continue with it
The intravenous medicine helps shorten hospital recovery times, says US govt data
The pandemic has exposed a clash among medical experts over disease transmission that stretches back nearly a century - to the very origins of germ theory
New cases of COVID-19 rose by nearly 69,000 across United States
A watchdog group raised the alarm over potentially dangerous levels of mercury in the creams more than seven months ago
The companies have been told to shut the production of painkiller drug
The treatment's chances of success are low if it is not administered to a patient during the early stages of the coronavirus infection, say experts
The Trump administration this week gave a major boost to Regeneron’s treatment, awarding the company $450 million to manufacture and supply as many as 300,000 doses
